2025. DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS. International journal of artificial intelligence. 5, 09 (Sep. 2025), 221–223.